Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biotin + silicon, specifically in the form of the Lustriva™ complex, is a patented dietary supplement ingredient that combines inositol-stabilized arginine silicate (ASI) and magnesium biotinate. Developed by Nutrition21, this combination is engineered to enhance the bioavailability of both silicon and biotin compared to standard forms. Silicon plays a crucial role in the cross-linking of collagen and elastin fibers, contributing to the structural integrity of the skin and hair. Biotin is a vital cofactor for enzymes involved in the synthesis of keratin, the primary protein in hair and nails. Clinical research has shown that the complex can significantly increase hair thickness and improve skin health, particularly in women experiencing age-related thinning.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on biotin + silicon.